David Brusegard serves as Executive at GENEREX BIOTECHNOLOGY CORP, where they oversee executive responsibilities. Since joining the company, David Brusegard has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 16, 2016 involved exercising options for 1,667,671 shares valued at $0.
David Brusegard currently holds 5,615,070 shares of GENEREX BIOTECHNOLOGY CORP (GNBT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David Brusegard has been a net neutral trader of GNBT stock. They have purchased $0 and sold $0 worth of shares.
David Brusegard's most recent insider trade was on Feb 16, 2016, when they sold 1,667,671 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| 5,583,775 |
| $N/A |
| Discretionary |